Zensar Technologies has announced the successful completion of the merger of its US-based subsidiary, M3BI LLC, with Zensar Technologies Inc., USA. This follows the earlier merger of Bridgeview Life Sciences LLC. The merger of M3BI LLC was completed with relevant local authorities on August 13, 2026, and becomes effective from September 1, 2026. All requisite filings for both mergers are now finalized, with post-merger processes underway.
Zensar Technologies Completes Key US Subsidiary Merger
Zensar Technologies Limited has confirmed the completion of a significant merger involving its US-based wholly owned step-down subsidiary. Following an in-principle approval by the Board of Directors, M3BI LLC has been merged with Zensar Technologies Inc., USA, a material wholly owned subsidiary of the company.
Merger Details and Effective Date
The company announced that all requisite filings concerning the merger of M3BI LLC were finalized with the relevant local authorities and state agencies on August 13, 2026. This merger is set to become effective from September 1, 2026. Zensar Technologies received official intimation of this development at 1:43 a.m. (IST) on August 14, 2026.
Consolidation of US Operations
This development marks the culmination of the merger process for two key US-based subsidiaries, with Bridgeview Life Sciences LLC having been merged earlier. With the completion of these filings, all necessary procedures with local authorities and state agencies for both mergers have been concluded. Zensar Technologies anticipates that certain post-merger and consequential filings will be completed in due course.
Source: BSE
